Assessment of a pharmacist-driven point-of-care spirometry clinic within a primary care physicians office
| Autor: | Michael J. Cawley, William J. Warning, Richard Pacitti |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Spirometry
medicine.medical_specialty medicine.drug_class Point-of-Care Systems Pharmacist lcsh:RS1-441 Pharmacists mesh:Spirometry lcsh:Pharmacy and materia medica Ambulatory care Bronchodilator Internal medicine medicine mesh:Pharmacists Original Research Asthma medicine.diagnostic_test business.industry lcsh:RM1-950 medicine.disease United States Discontinuation Clinical pharmacy lcsh:Therapeutics. Pharmacology mesh:Point-of-Care Systems Physical therapy mesh:United States business Cohort study |
| Zdroj: | Pharmacy Practice (Granada) v.9 n.4 2011 SciELO España. Revistas Científicas Españolas de Ciencias de la Salud instname Pharmacy Practice, Vol 9, Iss 4, Pp 221-227 (2011) Pharmacy Practice |
| ISSN: | 2008-2010 |
| Popis: | Objective: To assess value-added service of a pharmacist-driven point-of-care spirometry clinic to quantify respiratory disease abnormalities within a primary care physicians office Methods: This retrospective, cohort study was an analysis of physician referred patients who attended our spirometry clinic during 2008-2010 due to pulmonary symptoms or disease. After spirometry testing, data was collected retrospectively to include patient demographics, spirometry results, and pulmonary pharmaceutical interventions. Abnormal spirometry was identified as an obstructive and/or restrictive defect. Results: Sixty-five patients with a primary diagnosis of cough, shortness of breath, or diagnosis of asthma or chronic obstructive pulmonary disease were referred to the spirometry clinic for evaluation. A total of 51 (32 patients with normal spirometry, 19 abnormal spirometry) completed their scheduled appointment. Calculated lung age was lower in normal spirometry (58.1; SD=20 yrs) than abnormal spirometry (78.2; SD=7.5 yrs, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|